Stem cell treatment for knee osteoarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests a potential new treatment for knee osteoarthritis using stem cells from umbilical cord tissue. The therapy is injected into the knee to see if it can reduce pain and improve function, and it's being compared to a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have knee osteoarthritis (Grade I to IV) seen on an X-ray.
- You've had knee pain for at least 3 months and your pain score on a WOMAC test is 7 or higher (out of 24).
- You are not pregnant, don't plan to become pregnant soon, and are willing to use birth control if needed.
- Your BMI is 40 or less, and you don't have severe knee deformities or unstable knee ligaments.
- You haven't had recent knee surgery or injections (like hyaluronic acid, steroids, or PRP) in the past 3–6 months.
- You don't have other serious health problems such as active cancer, infections, autoimmune diseases, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether stem cell injections can reduce pain and improve symptoms in people with knee or hip osteoarthritis. You may be considered if you have moderate-to-severe pain despite trying standard treatments.
This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This Phase 2 study tests whether injected umbilical-cord stem cells can improve safety and reduce symptoms in people with moderate knee osteoarthritis. It focuses on people with significant knee pain who have not gotten enough relief from standard, non-procedure treatments.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.